Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002)

X. Tan, P. Banerjee, A. Pha E, F. U.N. Rutaganira, K. Basu, N. Bota-Rabassedas, H. F. Guo, C. L. Grzeskowiak, X. Liu, J. Yu, L. Shi, D. H. Peng, B. L. Rodriguez, J. Zhang, V. Zheng, D. Y. Duose, L. M. Solis, B. Mino, M. G. Raso, C. BehrensI. I. Wistuba, K. L. Scott, M. Smith, K. Nguyen, G. Lam, I. Choong, A. Mazumdar, J. L. Hill, D. L. Gibbons, P. H. Brown, W. K. Russell, K. Shokat, C. J. Creighton, J. S. Glenn, J. M. Kurie

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the Research Article "PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma," two incorrect images were inserted into one figure (Fig. 3H). The PDF and HTML (full text) have been corrected.

Original languageEnglish (US)
Article numbereabb5995
JournalScience translational medicine
Volume12
Issue number535
DOIs
StatePublished - Mar 18 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002)'. Together they form a unique fingerprint.

Cite this